Automated virtual reality exposure therapy for spider phobia vs. in-vivo one-session treatment: A randomized non-inferiority trial

This study compared the efficacy of a technician-assisted single-session virtual reality exposure therapy (VRET) for the treatment of spider phobia featuring low-cost consumer-available hardware and novel automated software to gold-standard in-vivo one-session treatment (OST), using a parallel group...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Behaviour research and therapy 2019-07, Vol.118, p.130-140
Hauptverfasser: Miloff, Alexander, Lindner, Philip, Dafgård, Peter, Deak, Stefan, Garke, Maria, Hamilton, William, Heinsoo, Julia, Kristoffersson, Glenn, Rafi, Jonas, Sindemark, Kerstin, Sjölund, Jessica, Zenger, Maria, Reuterskiöld, Lena, Andersson, Gerhard, Carlbring, Per
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This study compared the efficacy of a technician-assisted single-session virtual reality exposure therapy (VRET) for the treatment of spider phobia featuring low-cost consumer-available hardware and novel automated software to gold-standard in-vivo one-session treatment (OST), using a parallel group randomized non-inferiority design. Method Participants (N = 100) were randomized to VRET and OST arms. Assessors blinded to treatment allocation evaluated participants at pre- and post-treatment as well follow-up (3 and 12 months) using a behavioral approach test (BAT) and self-rated fear of spider, anxiety, depression and quality-of-life scales. A maximum post-treatment difference of 2-points on the BAT qualified as non-inferiority margin. Results Linear mixed models noted large, significant reductions in behavioral avoidance and self-reported fear in both groups at post-treatment, with VRET approaching the strong treatment benefits of OST over time. Non-inferiority was identified at 3- and 12- months follow-up but was significantly worse until 12-months. There was no significant difference on a questionnaire measuring negative effects. Conclusions Automated VRET efficaciously reduced spider phobia symptoms in the short-term and was non-inferior to in-vivo exposure therapy in the long-term. VRET effectiveness trials are warranted to evaluate real-world benefits and non-specific therapeutic factors accruing from the presence of a technician during treatment. ClinicalTrials.gov (NCT02533310). •Non-inferiority of virtual reality exposure therapy (VRET) for spider phobia tested.•Patients (N = 100) were randomized to VRET or in-vivo one-session treatment (OST).•Technician-assisted automated VRET significantly reduced fear of spider self-report.•Non-inferiority obtained at 3- and 12-months according to behavioral approach test.•Future studies warranted to evaluate real-world effectiveness in self-help format.
ISSN:0005-7967
1873-622X
1873-622X
DOI:10.1016/j.brat.2019.04.004